Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: Brazil Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202018
202113
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated11
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
BioNTech SE2
D'Or Institute for Research and Education2
Merck Sharp & Dohme LLC2
University of Sao Paulo2
ARCA Biopharma, Inc.1
Abivax S.A.1
AstraZeneca1
Biophytis1
Butantan Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1933
Coronavirus Infections6
Pneumonia4
Inflammation2
Cardiovascular Diseases1
Coronaviridae Infections1
Nidovirales Infections1
RNA Virus Infections1
Severe Acute Respiratory Syndrome1
Stress Disorders, Post-Traumatic1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.